Multiple Assemblies exist for SMTL entry 6m4w
Crystal structure of MBP fused split FKBP-FRB T2098L mutant in complex with rapamycin; X-RAY DIFFRACTION 3.11 Å

	SMTL ID 6m4w.1 Ligands alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose; RAPAMYCIN IMMUNOSUPPRESSANT DRUG; GLYCEROL Polypeptides chimera of Maltose/maltodextrin-binding periplasmic protein and Peptidyl-prolyl cis-trans isomerase FKBP1A; Peptidyl-prolyl cis-trans isomerase FKBP1A; Serine/threonine-protein kinase mTOR Oligo-state hetero-1-1-1-mer
	SMTL ID 6m4w.2 Ligands alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose; RAPAMYCIN IMMUNOSUPPRESSANT DRUG Polypeptides chimera of Maltose/maltodextrin-binding periplasmic protein and Peptidyl-prolyl cis-trans isomerase FKBP1A; Peptidyl-prolyl cis-trans isomerase FKBP1A; Serine/threonine-protein kinase mTOR Oligo-state hetero-1-1-1-mer
	SMTL ID 6m4w.3 Ligands alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose; RAPAMYCIN IMMUNOSUPPRESSANT DRUG Polypeptides chimera of Maltose/maltodextrin-binding periplasmic protein and Peptidyl-prolyl cis-trans isomerase FKBP1A; Peptidyl-prolyl cis-trans isomerase FKBP1A; Serine/threonine-protein kinase mTOR Oligo-state hetero-1-1-1-mer